Paul Phillips
Concepts (268)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diplopia | 8 | 2024 | 20 | 2.550 |
Why?
| Exotropia | 7 | 2023 | 9 | 2.240 |
Why?
| Oculomotor Muscles | 5 | 2019 | 23 | 2.100 |
Why?
| Ocular Motility Disorders | 5 | 2018 | 17 | 2.050 |
Why?
| Ophthalmologic Surgical Procedures | 4 | 2019 | 21 | 1.970 |
Why?
| Pseudotumor Cerebri | 6 | 2018 | 24 | 1.870 |
Why?
| Vision, Low | 3 | 2022 | 9 | 1.790 |
Why?
| Optic Nerve | 6 | 2014 | 50 | 1.750 |
Why?
| Papilledema | 5 | 2022 | 27 | 1.550 |
Why?
| Optic Disk | 2 | 2023 | 17 | 1.480 |
Why?
| Intracranial Pressure | 5 | 2019 | 31 | 1.450 |
Why?
| Magnetic Resonance Imaging | 15 | 2023 | 1533 | 1.380 |
Why?
| Hypopituitarism | 4 | 2014 | 16 | 1.300 |
Why?
| Eye Abnormalities | 4 | 2023 | 24 | 1.250 |
Why?
| Child | 30 | 2024 | 6824 | 1.190 |
Why?
| Strabismus | 5 | 2019 | 15 | 1.180 |
Why?
| Ophthalmology | 2 | 2023 | 31 | 1.090 |
Why?
| Intracranial Hypertension | 3 | 2019 | 31 | 1.070 |
Why?
| Pituitary Gland | 3 | 2014 | 86 | 1.060 |
Why?
| Vision, Binocular | 4 | 2019 | 6 | 1.030 |
Why?
| Oculomotor Nerve Diseases | 2 | 2017 | 5 | 1.000 |
Why?
| Optic Nerve Diseases | 3 | 2023 | 23 | 1.000 |
Why?
| Humans | 64 | 2024 | 49827 | 0.860 |
Why?
| Vision Screening | 1 | 2022 | 12 | 0.840 |
Why?
| Fixation, Ocular | 3 | 2019 | 13 | 0.840 |
Why?
| Abducens Nerve Diseases | 2 | 2024 | 8 | 0.820 |
Why?
| Eye Diseases, Hereditary | 2 | 2017 | 5 | 0.790 |
Why?
| Tomography, Optical Coherence | 5 | 2022 | 95 | 0.780 |
Why?
| Dyslexia | 2 | 2018 | 55 | 0.730 |
Why?
| Distance Perception | 1 | 2019 | 3 | 0.710 |
Why?
| Postoperative Complications | 3 | 2015 | 1000 | 0.660 |
Why?
| Male | 34 | 2024 | 25093 | 0.650 |
Why?
| Orthoptics | 1 | 2018 | 1 | 0.640 |
Why?
| Child, Preschool | 19 | 2024 | 3853 | 0.620 |
Why?
| Adolescent | 14 | 2023 | 6340 | 0.590 |
Why?
| Visual Acuity | 9 | 2022 | 131 | 0.580 |
Why?
| Apraxias | 3 | 2013 | 9 | 0.570 |
Why?
| Cavernous Sinus | 2 | 2011 | 15 | 0.560 |
Why?
| Female | 32 | 2024 | 26329 | 0.560 |
Why?
| Retinal Hemorrhage | 3 | 2023 | 14 | 0.540 |
Why?
| Eyeglasses | 3 | 2023 | 9 | 0.530 |
Why?
| Diagnosis, Differential | 9 | 2018 | 1036 | 0.500 |
Why?
| Nervous System Diseases | 2 | 2005 | 88 | 0.480 |
Why?
| Blindness | 3 | 2024 | 31 | 0.480 |
Why?
| Developmental Disabilities | 2 | 2013 | 119 | 0.430 |
Why?
| Meningitis, Cryptococcal | 1 | 2012 | 10 | 0.410 |
Why?
| Blepharoptosis | 1 | 2012 | 13 | 0.410 |
Why?
| Cryptococcus neoformans | 1 | 2012 | 27 | 0.410 |
Why?
| Retinal Diseases | 2 | 2024 | 49 | 0.400 |
Why?
| Infant | 11 | 2024 | 3551 | 0.400 |
Why?
| Carotid Artery, Internal, Dissection | 1 | 2011 | 8 | 0.390 |
Why?
| Brain Diseases | 2 | 2012 | 82 | 0.390 |
Why?
| Tuberous Sclerosis | 1 | 2011 | 37 | 0.380 |
Why?
| Intracranial Aneurysm | 1 | 2011 | 48 | 0.380 |
Why?
| Neurofibromatosis 1 | 1 | 2010 | 32 | 0.370 |
Why?
| Vision Disorders | 2 | 2022 | 55 | 0.350 |
Why?
| Retrospective Studies | 10 | 2024 | 6117 | 0.340 |
Why?
| Optic Disk Drusen | 1 | 2009 | 3 | 0.330 |
Why?
| Hemianopsia | 1 | 2009 | 5 | 0.330 |
Why?
| Young Adult | 6 | 2023 | 3936 | 0.330 |
Why?
| Cerebrospinal Fluid Shunts | 1 | 2008 | 21 | 0.320 |
Why?
| Dyskeratosis Congenita | 1 | 2008 | 2 | 0.320 |
Why?
| Rhombencephalon | 1 | 2007 | 4 | 0.310 |
Why?
| Cerebellum | 2 | 2013 | 133 | 0.310 |
Why?
| Adrenoleukodystrophy | 1 | 2007 | 1 | 0.310 |
Why?
| Botulinum Toxins | 1 | 2007 | 5 | 0.300 |
Why?
| Membrane Proteins | 2 | 2024 | 342 | 0.300 |
Why?
| Adult | 11 | 2023 | 13160 | 0.290 |
Why?
| Visual Pathways | 2 | 2023 | 12 | 0.270 |
Why?
| United States | 5 | 2024 | 4838 | 0.270 |
Why?
| Fluorescein Angiography | 2 | 2022 | 27 | 0.260 |
Why?
| Craniocerebral Trauma | 2 | 2023 | 68 | 0.250 |
Why?
| Cerebrospinal Fluid Pressure | 2 | 2016 | 3 | 0.240 |
Why?
| Aqueous Humor | 1 | 2024 | 10 | 0.240 |
Why?
| Retinal Artery Occlusion | 1 | 2024 | 13 | 0.240 |
Why?
| Burns, Chemical | 1 | 2024 | 9 | 0.240 |
Why?
| Eye Injuries | 1 | 2024 | 26 | 0.230 |
Why?
| Retirement | 1 | 2023 | 17 | 0.230 |
Why?
| Diabetic Retinopathy | 1 | 2024 | 40 | 0.220 |
Why?
| Optic Chiasm | 1 | 2003 | 9 | 0.220 |
Why?
| Optic Atrophy, Hereditary, Leber | 1 | 2003 | 4 | 0.220 |
Why?
| Comprehension | 1 | 2024 | 110 | 0.210 |
Why?
| Retinal Ganglion Cells | 1 | 2022 | 10 | 0.210 |
Why?
| Forecasting | 1 | 2023 | 150 | 0.210 |
Why?
| Meningeal Neoplasms | 1 | 2023 | 51 | 0.210 |
Why?
| Aged | 6 | 2024 | 9272 | 0.210 |
Why?
| Central Nervous System Neoplasms | 1 | 2023 | 63 | 0.210 |
Why?
| Charcot-Marie-Tooth Disease | 1 | 2022 | 9 | 0.210 |
Why?
| Optic Atrophy | 1 | 2022 | 16 | 0.200 |
Why?
| Anesthetics, Combined | 1 | 2001 | 2 | 0.200 |
Why?
| Anesthesia, Local | 1 | 2001 | 15 | 0.200 |
Why?
| Internet | 1 | 2024 | 261 | 0.200 |
Why?
| Ophthalmoscopy | 2 | 2013 | 14 | 0.200 |
Why?
| Brain Injuries | 1 | 2023 | 160 | 0.200 |
Why?
| Prospective Studies | 4 | 2019 | 2344 | 0.190 |
Why?
| Giant Cell Arteritis | 1 | 2021 | 12 | 0.190 |
Why?
| Proteomics | 1 | 2024 | 328 | 0.190 |
Why?
| Middle Aged | 6 | 2024 | 11997 | 0.190 |
Why?
| Phacoemulsification | 1 | 2001 | 31 | 0.190 |
Why?
| Orbital Diseases | 1 | 2001 | 14 | 0.190 |
Why?
| Child Abuse | 1 | 2023 | 136 | 0.190 |
Why?
| Follow-Up Studies | 4 | 2019 | 2179 | 0.190 |
Why?
| Anesthetics, Local | 1 | 2001 | 75 | 0.190 |
Why?
| Vision Tests | 3 | 2023 | 13 | 0.190 |
Why?
| Choroiditis | 1 | 2020 | 9 | 0.190 |
Why?
| Macular Degeneration | 1 | 2021 | 47 | 0.190 |
Why?
| Multiple Sclerosis | 1 | 2021 | 65 | 0.190 |
Why?
| Socioeconomic Factors | 1 | 2023 | 580 | 0.180 |
Why?
| Health Status Disparities | 1 | 2023 | 195 | 0.180 |
Why?
| Cross-Sectional Studies | 4 | 2024 | 1541 | 0.180 |
Why?
| Mutation | 3 | 2017 | 1293 | 0.180 |
Why?
| Crohn Disease | 1 | 2020 | 89 | 0.170 |
Why?
| Vitreoretinal Surgery | 1 | 2019 | 7 | 0.170 |
Why?
| Healthcare Disparities | 1 | 2023 | 258 | 0.170 |
Why?
| Arteriovenous Fistula | 1 | 1999 | 21 | 0.170 |
Why?
| Carotid Artery Diseases | 1 | 1999 | 33 | 0.170 |
Why?
| Prevalence | 1 | 2022 | 943 | 0.170 |
Why?
| Sensitivity and Specificity | 2 | 2013 | 854 | 0.160 |
Why?
| Laser Therapy | 1 | 2019 | 83 | 0.160 |
Why?
| Retina | 2 | 2024 | 63 | 0.160 |
Why?
| Astigmatism | 1 | 2018 | 5 | 0.160 |
Why?
| Amblyopia | 1 | 2018 | 5 | 0.160 |
Why?
| Imaging, Three-Dimensional | 1 | 2019 | 149 | 0.160 |
Why?
| Mydriatics | 1 | 2018 | 12 | 0.160 |
Why?
| Pupil | 1 | 2018 | 30 | 0.160 |
Why?
| Sinus Thrombosis, Intracranial | 1 | 2018 | 17 | 0.150 |
Why?
| Convergence, Ocular | 1 | 2017 | 2 | 0.150 |
Why?
| Accommodation, Ocular | 1 | 2017 | 4 | 0.150 |
Why?
| Obesity | 3 | 2016 | 1113 | 0.150 |
Why?
| Myopia | 1 | 2017 | 7 | 0.150 |
Why?
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 10 | 0.150 |
Why?
| Keratoconus | 1 | 2017 | 4 | 0.150 |
Why?
| Reading | 1 | 2018 | 82 | 0.150 |
Why?
| Skin Diseases, Genetic | 1 | 2017 | 9 | 0.150 |
Why?
| Heterozygote | 1 | 2017 | 82 | 0.150 |
Why?
| Minocycline | 1 | 2017 | 15 | 0.150 |
Why?
| Cornea | 1 | 2017 | 51 | 0.150 |
Why?
| Subarachnoid Hemorrhage | 1 | 2018 | 65 | 0.150 |
Why?
| Joint Instability | 1 | 2017 | 40 | 0.140 |
Why?
| Arteries | 1 | 2017 | 94 | 0.140 |
Why?
| Carbonic Anhydrase Inhibitors | 1 | 2016 | 5 | 0.140 |
Why?
| Syndrome | 1 | 2017 | 234 | 0.140 |
Why?
| Acetazolamide | 1 | 2016 | 19 | 0.140 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2018 | 173 | 0.140 |
Why?
| Depth Perception | 2 | 2005 | 4 | 0.130 |
Why?
| Reproducibility of Results | 2 | 2024 | 1188 | 0.130 |
Why?
| Aged, 80 and over | 2 | 2019 | 3125 | 0.130 |
Why?
| Vascular Malformations | 1 | 2017 | 98 | 0.130 |
Why?
| Nevus of Ota | 1 | 2014 | 2 | 0.130 |
Why?
| Scleral Diseases | 1 | 2014 | 2 | 0.130 |
Why?
| Eye Neoplasms | 1 | 2014 | 10 | 0.130 |
Why?
| Chi-Square Distribution | 2 | 2005 | 282 | 0.120 |
Why?
| Siblings | 1 | 2014 | 33 | 0.120 |
Why?
| Functional Laterality | 1 | 2014 | 88 | 0.120 |
Why?
| Sex Factors | 2 | 2016 | 693 | 0.110 |
Why?
| Treatment Outcome | 3 | 2019 | 5138 | 0.110 |
Why?
| Cogan Syndrome | 1 | 2013 | 2 | 0.110 |
Why?
| Body Mass Index | 1 | 2016 | 652 | 0.110 |
Why?
| Kidney Diseases, Cystic | 1 | 2013 | 19 | 0.110 |
Why?
| Cerebellar Diseases | 1 | 2013 | 17 | 0.110 |
Why?
| Optic Nerve Neoplasms | 2 | 2004 | 8 | 0.110 |
Why?
| Stroke | 1 | 2018 | 492 | 0.110 |
Why?
| Case-Control Studies | 2 | 2005 | 1128 | 0.100 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 193 | 0.100 |
Why?
| Visual Fields | 2 | 2009 | 33 | 0.100 |
Why?
| Myasthenia Gravis | 1 | 2012 | 17 | 0.100 |
Why?
| Orbit | 2 | 2003 | 29 | 0.100 |
Why?
| Risk Assessment | 1 | 2016 | 1262 | 0.100 |
Why?
| Anti-Bacterial Agents | 1 | 2017 | 743 | 0.100 |
Why?
| Risk Factors | 2 | 2016 | 3619 | 0.100 |
Why?
| Acute Disease | 2 | 2021 | 369 | 0.090 |
Why?
| Optic Nerve Injuries | 1 | 2009 | 7 | 0.080 |
Why?
| Paranasal Sinuses | 1 | 2009 | 18 | 0.080 |
Why?
| Skin Neoplasms | 1 | 2014 | 487 | 0.080 |
Why?
| Decompression, Surgical | 1 | 2009 | 50 | 0.080 |
Why?
| Equipment Failure | 1 | 2008 | 62 | 0.080 |
Why?
| Hydrocephalus | 1 | 2008 | 42 | 0.080 |
Why?
| Endoscopy | 1 | 2009 | 124 | 0.080 |
Why?
| Blood Transfusion | 1 | 2008 | 121 | 0.070 |
Why?
| Tomography, X-Ray Computed | 2 | 2009 | 1159 | 0.070 |
Why?
| DNA, Mitochondrial | 2 | 2003 | 112 | 0.060 |
Why?
| Age Factors | 2 | 2019 | 1090 | 0.060 |
Why?
| Phosphopyruvate Hydratase | 1 | 2024 | 9 | 0.060 |
Why?
| Vitreous Body | 1 | 2024 | 19 | 0.060 |
Why?
| Prognosis | 1 | 2010 | 1952 | 0.060 |
Why?
| Bone Diseases, Developmental | 1 | 2024 | 14 | 0.060 |
Why?
| Paracentesis | 1 | 2024 | 13 | 0.060 |
Why?
| Eye Proteins | 1 | 2024 | 17 | 0.060 |
Why?
| Methylprednisolone | 2 | 2018 | 38 | 0.060 |
Why?
| Neuronal Ceroid-Lipofuscinoses | 1 | 2004 | 6 | 0.060 |
Why?
| Chromosomes, Human, Pair 15 | 1 | 2004 | 9 | 0.060 |
Why?
| Retinal Degeneration | 1 | 2004 | 11 | 0.060 |
Why?
| Vitrectomy | 1 | 2024 | 56 | 0.060 |
Why?
| Refraction, Ocular | 1 | 2023 | 7 | 0.060 |
Why?
| Exons | 1 | 2004 | 95 | 0.060 |
Why?
| Molecular Chaperones | 1 | 2004 | 64 | 0.060 |
Why?
| Cultural Diversity | 1 | 2023 | 37 | 0.060 |
Why?
| Optic Atrophies, Hereditary | 1 | 2003 | 2 | 0.060 |
Why?
| Hematoma, Subdural | 1 | 2023 | 21 | 0.060 |
Why?
| Schools, Medical | 1 | 2023 | 69 | 0.060 |
Why?
| Hypertrophy | 1 | 2003 | 50 | 0.050 |
Why?
| Chromosome Deletion | 1 | 2004 | 141 | 0.050 |
Why?
| Ischemia | 1 | 2024 | 152 | 0.050 |
Why?
| Mass Spectrometry | 1 | 2024 | 306 | 0.050 |
Why?
| Biopsy | 2 | 2021 | 582 | 0.050 |
Why?
| DNA Mutational Analysis | 1 | 2003 | 175 | 0.050 |
Why?
| Faculty, Medical | 1 | 2023 | 90 | 0.050 |
Why?
| Membrane Glycoproteins | 1 | 2004 | 240 | 0.050 |
Why?
| Health Literacy | 1 | 2024 | 129 | 0.050 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2004 | 152 | 0.050 |
Why?
| Vaccination | 1 | 2024 | 268 | 0.050 |
Why?
| Needlestick Injuries | 1 | 2001 | 3 | 0.050 |
Why?
| Pituitary Hormones | 1 | 2001 | 18 | 0.050 |
Why?
| Scotoma | 1 | 2021 | 7 | 0.050 |
Why?
| Lens Implantation, Intraocular | 1 | 2001 | 22 | 0.050 |
Why?
| Fundus Oculi | 1 | 2021 | 23 | 0.050 |
Why?
| Bupivacaine | 1 | 2001 | 28 | 0.050 |
Why?
| Spinal Puncture | 2 | 2018 | 16 | 0.050 |
Why?
| Temporal Arteries | 1 | 2021 | 15 | 0.050 |
Why?
| Lidocaine | 1 | 2001 | 49 | 0.050 |
Why?
| Patient Education as Topic | 1 | 2024 | 295 | 0.050 |
Why?
| Macrophages | 1 | 2024 | 364 | 0.050 |
Why?
| Mucormycosis | 1 | 2001 | 29 | 0.050 |
Why?
| Graves Disease | 1 | 2001 | 18 | 0.050 |
Why?
| Eye Infections, Fungal | 1 | 2001 | 19 | 0.050 |
Why?
| Pilot Projects | 1 | 2023 | 699 | 0.050 |
Why?
| Intravitreal Injections | 1 | 2020 | 35 | 0.050 |
Why?
| Saccades | 1 | 2000 | 4 | 0.050 |
Why?
| Pedigree | 1 | 2000 | 122 | 0.040 |
Why?
| Aspergillosis | 1 | 2001 | 125 | 0.040 |
Why?
| Emergency Service, Hospital | 1 | 2024 | 488 | 0.040 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2020 | 201 | 0.040 |
Why?
| Trochlear Nerve | 1 | 1999 | 1 | 0.040 |
Why?
| Ophthalmoplegia | 1 | 1999 | 6 | 0.040 |
Why?
| Angiogenesis Inhibitors | 1 | 2020 | 187 | 0.040 |
Why?
| Postoperative Care | 1 | 2019 | 104 | 0.040 |
Why?
| Cranial Nerve Diseases | 1 | 1999 | 14 | 0.040 |
Why?
| Pandemics | 1 | 2024 | 554 | 0.040 |
Why?
| Refractive Errors | 1 | 2018 | 6 | 0.040 |
Why?
| Tropicamide | 1 | 2018 | 5 | 0.040 |
Why?
| Cyclopentolate | 1 | 2018 | 5 | 0.040 |
Why?
| Equipment Design | 1 | 2019 | 282 | 0.040 |
Why?
| Phenylephrine | 1 | 2018 | 34 | 0.040 |
Why?
| Drug Combinations | 1 | 2018 | 123 | 0.040 |
Why?
| Lung Neoplasms | 1 | 2004 | 605 | 0.040 |
Why?
| Phlebography | 1 | 2018 | 62 | 0.040 |
Why?
| Corneal Topography | 1 | 2017 | 6 | 0.040 |
Why?
| Corneal Pachymetry | 1 | 2017 | 5 | 0.040 |
Why?
| Dilatation, Pathologic | 1 | 2017 | 23 | 0.040 |
Why?
| Sexual Maturation | 1 | 2016 | 14 | 0.040 |
Why?
| Sex Distribution | 1 | 2016 | 135 | 0.030 |
Why?
| Age Distribution | 1 | 2016 | 170 | 0.030 |
Why?
| Glucocorticoids | 1 | 2018 | 219 | 0.030 |
Why?
| Morbidity | 1 | 2016 | 138 | 0.030 |
Why?
| Disease Progression | 1 | 2018 | 822 | 0.030 |
Why?
| Cytoskeletal Proteins | 1 | 2013 | 49 | 0.030 |
Why?
| Abnormalities, Multiple | 1 | 2013 | 167 | 0.020 |
Why?
| Recovery of Function | 1 | 2009 | 189 | 0.020 |
Why?
| Brain | 2 | 2004 | 1309 | 0.020 |
Why?
| Electroretinography | 1 | 2004 | 15 | 0.010 |
Why?
| Microscopy, Electron | 1 | 2004 | 77 | 0.010 |
Why?
| Neurologic Examination | 1 | 2004 | 77 | 0.010 |
Why?
| Alleles | 1 | 2004 | 251 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 2004 | 455 | 0.010 |
Why?
| Electroencephalography | 1 | 2004 | 306 | 0.010 |
Why?
| Hemorrhage | 1 | 2003 | 202 | 0.010 |
Why?
| Skin | 1 | 2004 | 407 | 0.010 |
Why?
| Muscle, Skeletal | 1 | 2004 | 750 | 0.010 |
Why?
|
|
Phillips's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|